Borgazon 0.1% cream 20 g

Tradename

Borgazon

Borgasone

Composition

Each 100 g of cream contains:

Mometasone furoate 0.1 g

Properties

GCS for external use. It has anti-inflammatory, antipruritic and antiexudative effects. GCS induce the release of proteins that inhibit phospholipase A2, known collectively as lipocortins, which control the biosynthesis of inflammatory mediators such as prostaglandins and leukotrienes by inhibiting the release of their common precursor, arachidonic acid.

Indications

Inflammatory reactions and itching in dermatoses amenable to GCS therapy.

Method of administration and dosage:

Apply a cream or ointment externally.

Contraindications

Hypersensitivity to mometasone; rosacea; perioral dermatitis; bacterial, viral (Herpes simplex, Herpes zoster, chickenpox), fungal skin infection; tuberculosis; syphilis; postvaccination reactions; pregnancy (use on large areas of the skin, long-term treatment); lactation period (use in high doses and / or for a long time); children under 2 years old.

Use with caution on the face and intertriginous skin, use occlusive dressings, and apply on large areas of the skin and / or for a long time (especially in children).

Precautions:

Side effects

Infections and invasions: rarely — folliculitis, secondary infection.

On the part of the skin and subcutaneous tissues: rarely — irritation and dryness of the skin, burning sensation, itching, hypertrichosis, acne, hypopigmentation, perioral dermatitis, allergic contact dermatitis, accession of a secondary infection, skin maceration, signs of skin atrophy, striae, prickly heat, formation papules, pustules.

From the side of the nervous system: the frequency has not been established paresthesia.